Four Off-Label Medications for Long Covid to be Reimbursed by Health Insurers

In Germany, a decision has been made to reimburse four medications for Long Covid and Post-Covid by health insurance companies, despite them being approved for other indications, as there are currently no approved drugs specifically for these conditions.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

fazGerman4d ago

Off-Label: Vier Medikamente gegen Long Covid

Bislang gibt es keine zugelassenen Arzneien gegen Long Covid und Post-Covid. Nun wurde aber entschieden, dass vier Medikamente von den Krankenkassen erstattet werden, die eigentlich für andere Indikationen zugelassen sind.

Read full article →

PERSPECTA

PERSPECTA

Four Off-Label Medications for Long Covid to be Reimbursed by Health Insurers

Sources

Off-Label: Vier Medikamente gegen Long Covid

Related Stories

Cleft Lip and Palate Patients Receive Free Surgery in Masbate

Davao del Sur Declared Bird Flu-Free After Outbreak Resolution

Denmark Introduces Anonymous Counseling for Parents Committing Violence

Finnish Healthcare Experiment Fails to Reduce Income Disparities in Private Doctor Use

PERSPECTA